Retatrutide – 5mg

Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors while uniquely activating the glucagon receptor. This additional receptor interaction boosts glucagon production, promoting the breakdown of stored fats and glycogen, which increases basal metabolism and supports more consistent fat loss. By acting on GLP-1 and GIP receptors, Retatrutide also delays gastric emptying and enhances appetite control, providing a multifaceted approach to obesity research that sets it apart from traditional GLP-1 agonists. While its potential benefits are promising, further research is required to fully understand its therapeutic applications.